OtherIndex FundsDirect · Growth
ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth
ICICI Prudential · Scheme 150930
₹20.42▲ 0.07%NAV · 2026-09-18
Excellent FundScore
AUM
₹148 cr
Expense ratio
0.52%
3Y CAGR
20.0%
Risk level
High
Min SIP
₹1,000
Benchmark
Underlying index
Fund manager: Nishit PatelExit load: Nil
Excellent · 89/100
A standout fund on our data — strong across almost every dimension.
🎯 A dependable core holding for long-term SIP investors.
📈 Why it could do well
- ✓Compounding well recently — 20.0% CAGR over 3 years.
- ✓Very consistent — delivers dependably across market cycles, ideal for SIPs.
- ✓Protects capital well — worst-ever fall was only 17%.
- ✓Low cost — 0.52% expense ratio means more of the return stays with you.
- ✓3Y CAGR: +20.0%
- ✓Positive 3Y windows: 100% of rolling 3Y windows positive
📉 What could drag it down
- •No major red flags on our data — but all mutual funds carry market risk.
FundScore breakdown
89/100 · Excellent
Returns
Excellent
Consistency
Excellent
Risk-adjusted
Decent
Downside protection
Excellent
Cost efficiency
Excellent
Portfolio quality
Average
Each dial rates the fund 0–100 on one factor, computed from real NAV history. Fuller & greener = stronger.
SIP return calculator
Back-tested on this fund's actual historical NAVs. Past performance ≠ future returns.